Headlines

Who gets to own the Luigi Mangione story?

On Monday morning, a judge overseeing the New York state case on the killing of the UnitedHealthcare CEO ruled that some evidence collected by police could not be shown to a jury. It wasn't the only news coming out of the hearing. Outside the courthouse, Molly Crane-Newman, a

Perfidious empire

Tell me lies, tell me sweet little lies Tell me lies Tell me, tell me lies Oh no-no, you can’t disguise – Fleetwood Mac Perfidy. There is no other word to describe the assassination of Iran’s leadership while negotiations were ongoing. It does not matter how evil they were, nor

Asia

Philips’ new display has a screen on both sides

Its name might be dull and uninspired, but the Philips 24B2D5300 Business Monitor brings a novel feature I've never seen on a display before: screens on either side. The design will primarily benefit people who are constantly angling their computer screen so those on both sides

Tech

Required Reading

This week: a mysterious LA guerrilla artist, Whistler and gold paint, remembering Totó La Momposina, the art of photographing queer nightlife, AI agents turn Marxist, and more.

The Secret to Winning on Jeopardy . “To win on...

The Secret to Winning on Jeopardy . “To win on Jeopardy, you don’t need to learn everything. You just need to learn one thing about everything.” As an proficient player of Yell Answers At The TV Jeopardy in my teen years, I can confirm this strat.

Trump Tells Republicans to Defend His Slush Fund by Lying

Ahead of a meeting with acting Attorney General Todd Blanche, the White House sent a document to GOP senators on Thursday explaining why President Donald Trump’s $1.8 billion slush fund is actually a great idea. The document says the fund is about “seeking accountability” for

New obesity drug from Lilly delivers major weight loss

An investigational obesity drug from Eli Lilly cleared important end points in a late-stage trial, the company said Thursday, by helping patients lose up to 30 percent of their body weight. Lilly said that a once-weekly injection of retatrutide met the primary endpoint in a